Citation only
via OpenAlex
Epigenetic Clocks and Biological Ageing: From Biomarker to Intervention Target
Monika Barsagade, Ravi Kishore Agrawal
Integrative Biomedical Research · 2026
Abstract
Chronological age is a poor proxy for the true physiological state of an individual, and this mismatch has driven a decade-long search for molecular biomarkers capable of tracking biological age directly. Among the candidates that have emerged from genomics, transcriptomics, proteomics and metabolomics, biomarkers derived from DNA methylation—so-called epigenetic clocks—have proved the most reproducible and the most clinically informative. Here we trace their evolution from first-generation estimators trained to predict chronological age, through second-generation clocks trained on clinical morbidity and mortality outcomes, to third-generation “pace of ageing” metrics and, most recently, resilience-oriented multi-omics frameworks such as EpiAge-R that attempt to separate degenerative methylation noise from active repair signal. We show how epigenetic age acceleration tracks mortality, cardiovascular disease, cancer, neurodegeneration and frailty across large cohorts, how minimalist targeted-CpG assays are beginning to make biological age screening scalable outside specialist laboratories, and how randomized and pilot trials of multidomain lifestyle, dietary and micronutrient interventions have repeatedly demonstrated measurable deceleration—and in some cohorts apparent reversal—of biological age. We argue that epigenetic clocks are best understood not as static descriptive biomarkers but as dynamic, intervention-sensitive endpoints, and we outline the technical noise, tissue specificity and population-reference biases that currently stand between this promise and its responsible use in individual patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.25163/biomedical.10110885
- Canonical
- link ↗
- Fetched
- 2026-10-14 MST
Cite this
APA
Barsagade, M., & Agrawal, R.K. (2026). Epigenetic Clocks and Biological Ageing: From Biomarker to Intervention Target. <em>Integrative Biomedical Research</em>. https://doi.org/10.25163/biomedical.10110885
Vancouver
Barsagade M, Agrawal RK. Epigenetic Clocks and Biological Ageing: From Biomarker to Intervention Target. Integrative Biomedical Research. 2026. doi:10.25163/biomedical.10110885.
BibTeX
@article{monika2026Epigen,
title = {Epigenetic Clocks and Biological Ageing: From Biomarker to Intervention Target},
author = {Monika Barsagade and Ravi Kishore Agrawal},
journal = {Integrative Biomedical Research},
year = {2026},
doi = {10.25163/biomedical.10110885},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Cancer 2021
Citation only
DNA methylation age as a biomarker for cancer
Elsevier eBooks 2017
Citation only
Epigenetic Biomarkers for Biological Age
Journal of Internal Medicine 2022
Citation only
Epigenetic aging: Biological age prediction and informing a mechanistic theory of aging
Aging cell 2026
Open access · OA
Biological Versus Technical Reliability of Epigenetic Clocks and Implications for Disease Prognosis and Intervention Response.
Briefings in Bioinformatics 2022
Preprint · OA
Evaluation of different computational methods for DNA methylation-based biological age
Aging Cell 2026
Open access · CC-BY